Kisho

Centocor, Inc. — Rare Disease Pipeline | Kisho | Kisho

Centocor, Inc.

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
Behcet disease	Remicade	Orphan Designation	-
Crohn disease	Remicade	Orphan Designation	-
MALT lymphoma	Human Anti-tumor Necrosis factor alpha monoclonal antibody	Orphan Designation	-
TORCH syndrome	Human IgM monoclonal antibody (C-58) To CMV	Orphan Designation	-
anosmia for isobutyric acid	Remicade	Orphan Designation	-
autoinflammatory syndrome, familial, Behcet-like 1	Remicade	Orphan Designation	-
birdshot chorioretinopathy	Human Anti-tumor Necrosis factor alpha monoclonal antibody	Orphan Designation	-
chronic inflammatory demyelinating polyradiculoneuropathy	golimumabInfliximab	Orphan Designation	-
chronic primary adrenal insufficiency	golimumabInfliximab	Orphan Designation	-
chronic recurrent multifocal osteomyelitis	golimumabInfliximab	Orphan Designation	-
congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome	Remicade	Orphan Designation	-
cytomegalovirus infection	Human IgM monoclonal antibody (C-58) To CMV	Orphan Designation	-
developmental and epileptic encephalopathy 6B	Remicade	Orphan Designation	-
developmental and epileptic encephalopathy, 41	Remicade	Orphan Designation	-
glycogen storage disease VI	Remicade	Orphan Designation	-
heterotopia, periventricular, X-linked dominant	Nebacumab	Orphan Designation	-
inflammatory bowel disease 1	Remicade	Orphan Designation	-
interstitial lung disease specific to childhood	Remicade	Orphan Designation	-
juvenile idiopathic arthritis	infliximab	Orphan Designation	-
malignant pancreatic neoplasm	carlumabMonoclonal antibody 17-1a	Orphan Designation	-
multiple sclerosis	Chimeric M-T412 (human-murine) IgG monoclonal anti-CD4	Orphan Designation	-
myocarditis	Indium In 111 murine monoclonal antibody FAB to myosin	Orphan Designation	-
neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome	Remicade	Orphan Designation	-
neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities	Nebacumab	Orphan Designation	-
osteoporosis-pseudoglioma syndrome	Remicade	Orphan Designation	-
pediatric hepatocellular carcinoma	Remicade	Orphan Designation	-
pediatric-onset Graves disease	Remicade	Orphan Designation	-
phacoanaphylactic uveitis	Human Anti-tumor Necrosis factor alpha monoclonal antibody	Orphan Designation	-
severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome	Remicade	Orphan Designation	-
temporal arteritis	infliximab	Orphan Designation	-
thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies	Nebacumab	Orphan Designation	-

← Back to Companies